CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Trade 10x Genomics, Inc. - TXG CFD

    55.73
    7.23%
    0.14
    Low: 53.18
    High: 56.09
    Market Trading Hours* (UTC) Opens on Monday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.14
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		-0.024874%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Go to platform
    		0.002651%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 20%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 51.97
    Open* 53.18
    1-Year Change* -28.68%
    Day's Range* 53.18 - 56.09
    52 wk Range 23.81-83.34
    Average Volume (10 days) 754.85K
    Average Volume (3 months) 21.21M
    Market Cap 6.00B
    P/E Ratio -100.00K
    Shares Outstanding 115.36M
    Revenue 516.41M
    EPS -1.46
    Dividend (Yield %) N/A
    Beta 1.74
    Next Earnings Date May 2, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 31, 2023 55.73 3.30 6.29% 52.43 56.16 52.01
    Mar 30, 2023 51.97 0.76 1.48% 51.21 52.32 51.07
    Mar 29, 2023 50.69 1.41 2.86% 49.28 50.98 49.00
    Mar 28, 2023 48.81 -0.45 -0.91% 49.26 49.42 48.27
    Mar 27, 2023 49.70 -0.68 -1.35% 50.38 51.52 49.29
    Mar 24, 2023 50.12 2.16 4.50% 47.96 50.30 47.65
    Mar 23, 2023 48.97 0.03 0.06% 48.94 51.49 48.48
    Mar 22, 2023 48.69 -1.39 -2.78% 50.08 51.08 48.61
    Mar 21, 2023 50.03 1.83 3.80% 48.20 50.25 47.91
    Mar 20, 2023 47.76 0.30 0.63% 47.46 48.56 46.76
    Mar 17, 2023 48.08 -1.09 -2.22% 49.17 49.71 47.66
    Mar 16, 2023 50.25 2.49 5.21% 47.76 50.90 47.60
    Mar 15, 2023 48.54 1.45 3.08% 47.09 49.32 47.08
    Mar 14, 2023 48.63 0.07 0.14% 48.56 49.52 48.06
    Mar 13, 2023 47.44 3.47 7.89% 43.97 49.32 43.97
    Mar 10, 2023 44.93 -1.55 -3.33% 46.48 46.49 43.15
    Mar 9, 2023 47.00 -1.65 -3.39% 48.65 49.98 46.93
    Mar 8, 2023 48.95 1.16 2.43% 47.79 49.49 47.24
    Mar 7, 2023 48.16 0.10 0.21% 48.06 49.75 47.48
    Mar 6, 2023 48.39 -2.30 -4.54% 50.69 50.80 48.13

    10x Genomics, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 516.409 490.49 298.845 245.893 146.313
    Revenue 516.409 490.49 298.845 245.893 146.313
    Cost of Revenue, Total 120.386 74.091 58.468 61.033 28.661
    Gross Profit 396.023 416.399 240.377 184.86 117.652
    Total Operating Expense 684.353 542.743 834.508 276.466 257.077
    Selling/General/Admin. Expenses, Total 298.3 257.56 199.726 130.834 87.936
    Research & Development 265.667 211.752 570.923 83.097 109.9
    Other Operating Expenses, Total 0 -0.66 1.27 1.502 30.58
    Operating Income -167.944 -52.253 -535.663 -30.573 -110.764
    Interest Income (Expense), Net Non-Operating 6.171 -0.66 -0.15 -0.274 -1.385
    Other, Net -0.198 -0.802 1.337 -0.186 -0.249
    Net Income Before Taxes -161.971 -53.715 -534.476 -31.033 -112.398
    Net Income After Taxes -166 -58.223 -542.731 -31.251 -112.485
    Net Income Before Extra. Items -166 -58.223 -542.731 -31.251 -112.485
    Total Extraordinary Items
    Net Income -166 -58.223 -542.731 -31.251 -112.485
    Income Available to Common Excl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
    Income Available to Common Incl. Extra. Items -166 -58.223 -542.731 -31.251 -112.485
    Diluted Net Income -166 -58.223 -542.731 -31.251 -112.485
    Diluted Weighted Average Shares 113.859 110.348 101.152 96.2416 93.8497
    Diluted EPS Excluding Extraordinary Items -1.45795 -0.52763 -5.36552 -0.32471 -1.19857
    Diluted Normalized EPS -1.45795 -0.52763 -5.33904 -0.32471 -1.19857
    Unusual Expense (Income) 0 0 4.121
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Total revenue 156.232 131.072 114.609 114.496 143.53
    Revenue 156.232 131.072 114.609 114.496 143.53
    Cost of Revenue, Total 36.827 30.377 27.704 25.478 27.598
    Gross Profit 119.405 100.695 86.905 89.018 115.932
    Total Operating Expense 179.328 171.068 177.726 156.231 159.36
    Selling/General/Admin. Expenses, Total 78.887 73.401 79.337 66.675 69.877
    Research & Development 63.614 67.29 70.685 64.078 61.885
    Unusual Expense (Income) 0 0
    Other Operating Expenses, Total 0 0 0 0
    Operating Income -23.096 -39.996 -63.117 -41.735 -15.83
    Interest Income (Expense), Net Non-Operating 2.69 1.911 1.129 0.441 -0.168
    Other, Net 3.995 -1.95 -1.843 -0.4 0.005
    Net Income Before Taxes -16.411 -40.035 -63.831 -41.694 -15.993
    Net Income After Taxes -17.215 -41.914 -64.458 -42.413 -18.449
    Net Income Before Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
    Net Income -17.215 -41.914 -64.458 -42.413 -18.449
    Income Available to Common Excl. Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
    Income Available to Common Incl. Extra. Items -17.215 -41.914 -64.458 -42.413 -18.449
    Diluted Net Income -17.215 -41.914 -64.458 -42.413 -18.449
    Diluted Weighted Average Shares 114.767 114.112 113.575 112.966 111.913
    Diluted EPS Excluding Extraordinary Items -0.15 -0.3673 -0.56754 -0.37545 -0.16485
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -0.15 -0.3673 -0.56754 -0.37545 -0.16485
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 747.591 774.366 480.84 106.236 68.107
    Cash and Short Term Investments 587.447 663.603 424.166 65.08 47.857
    Cash & Equivalents 587.447 663.603 424.166 65.08 47.857
    Total Receivables, Net 85.254 51.208 33.371 29.566 13.341
    Accounts Receivable - Trade, Net 85.254 51.208 33.371 28.088 13.341
    Total Inventory 59.966 29.959 15.27 8.57 4.838
    Prepaid Expenses 13.896 13.029 8.033 3.02 2.071
    Total Assets 1018.83 929.341 605.923 124.31 75.609
    Property/Plant/Equipment, Total - Net 230.41 119.823 48.821 11.127 6.925
    Property/Plant/Equipment, Total - Gross 279.431 150.325 67.876 25.21 17.958
    Accumulated Depreciation, Total -49.021 -30.502 -19.055 -14.083 -11.033
    Other Long Term Assets, Total 10.917 12.798 76.262 6.947 0.577
    Total Current Liabilities 110.357 118.126 63.049 32.362 22.141
    Accounts Payable 17.351 4.709 13.028 8.792 5.443
    Accrued Expenses 75.821 92.326 30.035 12.118 8.959
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 9.882 4.187 4.224
    Other Current Liabilities, Total 17.185 21.091 10.104 7.265 3.515
    Total Liabilities 201.258 190.269 185.84 101.053 29.704
    Total Long Term Debt 0 0 19.837 25.489 6.335
    Long Term Debt 0 19.837 25.489 6.335
    Other Liabilities, Total 90.901 72.143 102.954 43.202 1.228
    Total Equity 817.568 739.072 420.083 23.257 45.905
    Redeemable Preferred Stock 0 243.244 158.414
    Common Stock 0.002 0.002 0.002 0.001 0.001
    Additional Paid-In Capital 1680.86 1544.22 682.494 11.165 6.136
    Retained Earnings (Accumulated Deficit) -863.321 -805.098 -262.367 -231.116 -118.631
    Other Equity, Total 0.022 -0.05 -0.046 -0.037 -0.015
    Total Liabilities & Shareholders’ Equity 1018.83 929.341 605.923 124.31 75.609
    Total Common Shares Outstanding 112.515 108.486 96.2416 93.8497 93.8497
    Other Current Assets, Total 1.028 16.567
    Intangibles, Net 25.397 22.354
    Goodwill, Net 4.511
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 697.335 747.591 744.104 757.174 745.716
    Cash and Short Term Investments 539.323 587.447 600.44 621.958 617.195
    Cash & Equivalents 312.487 587.447 600.44 621.958 617.195
    Total Receivables, Net 76.526 85.254 78.43 59.68 57.408
    Accounts Receivable - Trade, Net 76.526 85.254 78.43 59.68 57.408
    Total Inventory 63.697 59.966 51.141 44.087 38.507
    Prepaid Expenses 17.762 13.896 14.065 13.298 14.442
    Other Current Assets, Total 0.027 1.028 0.028 18.151 18.164
    Total Assets 1003.25 1018.83 990.572 977.579 954.033
    Property/Plant/Equipment, Total - Net 265.88 230.41 203.304 176.454 163.666
    Property/Plant/Equipment, Total - Gross 279.431 247.698 215.665 198.415
    Accumulated Depreciation, Total -49.021 -44.394 -39.211 -34.749
    Goodwill, Net 4.511 4.511 4.511 4.511 4.511
    Intangibles, Net 24.764 25.397 26.041 26.693 27.342
    Other Long Term Assets, Total 10.761 10.917 12.612 12.747 12.798
    Total Current Liabilities 94.446 110.357 100.375 113.126 120.549
    Accounts Payable 18.956 17.351 17.037 16.181 15.578
    Accrued Expenses 59.913 75.821 69.92 85.598 95.307
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 15.577 17.185 13.418 11.347 9.664
    Total Liabilities 196.566 201.258 190.351 192.993 201.573
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt 0
    Other Liabilities, Total 102.12 90.901 89.976 79.867 81.024
    Total Equity 806.685 817.568 800.221 784.586 752.46
    Common Stock 0.002 0.002 0.002 0.002 0.002
    Additional Paid-In Capital 1714.86 1680.86 1644.9 1612.23 1569.06
    Retained Earnings (Accumulated Deficit) -905.734 -863.321 -844.872 -827.701 -816.649
    Other Equity, Total -2.443 0.022 0.194 0.058 0.048
    Total Liabilities & Shareholders’ Equity 1003.25 1018.83 990.572 977.579 954.033
    Total Common Shares Outstanding 113.276 112.515 111.537 110.74 109.589
    Short Term Investments 226.836
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -166 -58.223 -542.731 -31.251 -112.485
    Cash From Operating Activities -33.606 -21.373 -217.898 34.627 -76.409
    Cash From Operating Activities 25.368 21.118 14.012 7.066 3.905
    Non-Cash Items 146.443 103.177 361.202 14.048 4.156
    Cash Taxes Paid 3.925 8.66 0.28 -0.022 -0.006
    Cash Interest Paid 0.841 1.222 1.67 2.25 1.824
    Changes in Working Capital -39.417 -87.445 -50.381 44.764 28.015
    Cash From Investing Activities -350.887 -106.729 -38.394 -42.767 -6.709
    Capital Expenditures -131.661 -101.278 -38.394 -42.767 -6.709
    Cash From Financing Activities 15.817 35.297 468.906 414.59 105.367
    Financing Cash Flow Items -5.409 -5.028 -5.848 0
    Issuance (Retirement) of Stock, Net 21.226 40.325 506.01 414.59 86.628
    Issuance (Retirement) of Debt, Net 0 0 -31.256 0 18.739
    Foreign Exchange Effects -0.044 0.234 -0.463 -0.045 -0.018
    Net Change in Cash -368.72 -92.571 212.151 406.405 22.231
    Other Investing Cash Flow Items, Total -219.226 -5.451
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -166 -148.785 -106.871 -42.413 -58.223
    Cash From Operating Activities -33.606 -47.329 -37.765 -20.802 -21.373
    Cash From Operating Activities 25.368 18.847 12.691 6.191 21.118
    Non-Cash Items 146.443 102.681 66.548 28.014 103.177
    Cash Taxes Paid 3.925 3.649 3.319 2.9 8.66
    Cash Interest Paid 0.841 0.841 0.841 0.841 1.222
    Changes in Working Capital -39.417 -20.072 -10.133 -12.594 -87.445
    Cash From Investing Activities -350.887 -317.715 -285.085 -257.558 -106.729
    Capital Expenditures -131.661 -91.927 -55.355 -28.136 -101.278
    Other Investing Cash Flow Items, Total -219.226 -225.788 -229.73 -229.422 -5.451
    Cash From Financing Activities 15.817 10.816 8.777 2.417 35.297
    Financing Cash Flow Items -5.409 -5.409 -5.409 -5.409 -5.028
    Issuance (Retirement) of Stock, Net 21.226 16.225 14.186 7.826 40.325
    Issuance (Retirement) of Debt, Net 0 0
    Foreign Exchange Effects -0.044 -0.295 -0.21 -0.018 0.234
    Net Change in Cash -368.72 -354.523 -314.283 -275.961 -92.571
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Morgan Stanley Investment Management Inc. (US) Investment Advisor/Hedge Fund 9.4813 9210082 -415196 2022-12-31 LOW
    Baillie Gifford & Co. Investment Advisor 8.8556 8602235 158847 2022-12-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.6523 8404774 145652 2022-12-31 LOW
    Paladin Capital Management, LLC Investment Advisor 8.3511 8112208 0 2022-03-31
    ARK Investment Management LLC Investment Advisor 4.4437 4316567 -260247 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 4.3422 4217954 207975 2022-12-31 LOW
    Sands Capital Management, LLC Investment Advisor 3.3012 3206783 -184394 2022-12-31 LOW
    Fidelity Management & Research Company LLC Investment Advisor 3.2549 3161803 -518131 2022-12-31 LOW
    SRS Investment Management, LLC Hedge Fund 3.0939 3005427 0 2022-12-31 LOW
    Generation Investment Management LLP Investment Advisor/Hedge Fund 2.6231 2548100 -57577 2022-12-31 LOW
    Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund 2.2421 2177988 -29270 2022-12-31 LOW
    Credit Suisse Asset Management Investment Advisor/Hedge Fund 2.1979 2135038 -17833 2022-12-31 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 2.018 1960300 -337642 2022-12-31 LOW
    Citadel Advisors LLC Hedge Fund 1.507 1463901 1108820 2022-12-31 HIGH
    Brown Capital Management, LLC Investment Advisor 1.4964 1453630 -161463 2022-12-31 LOW
    Foresite Capital Management, LLC Private Equity 1.3985 1358528 -1145000 2022-12-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3854 1345749 -18168 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3601 1321234 63324 2022-12-31 LOW
    Millennium Management LLC Hedge Fund 1.2491 1213394 999487 2022-12-31 HIGH
    JP Morgan Asset Management Investment Advisor 1.2158 1180996 27291 2022-12-31 LOW

    Start a global, multi-asset portfolio with an award-winning platform

    Trade now Desktop

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Profit/Loss

    10x Genomics, Inc. Company profile

    10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
    Industry: Laboratory Diagnostic & Testing Substances

    6230 Stoneridge Mall Road
    PLEASANTON
    CALIFORNIA 94588
    US

    Income Statement

    • Annual
    • Quarterly

    News

    A file photo shows a part of a stack of 500 Canadian gold coins, worth $1 million USD according to Sprott Money, is displayed at the precious metals dealer's booth at the Prospectors and Developers Association of Canada (PDAC) annual conference in Toronto

    PRECIOUS-Fed slowdown bets steer gold toward second quarterly rise

    Gold prices slipped on Friday, but the safe-haven metal was bound for its second straight quarterly rise after recent banking turmoil raised hopes of a less-aggressive U.S. Federal Reserve and shored up interest in bullion.

    09:37, 31 March 2023
    People use DBS automated teller machines (ATMs) in Singapore March 31, 2022.

    Singapore's DBS has seen inflows in SVB aftermath, CEO says

    DBS Group, Singapore's largest bank, has benefited from inflows amounting to a "few hundred millions" in the aftermath of the collapse of Silicon Valley Bank, its chief executive said on Friday.

    09:24, 31 March 2023
    Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., March 29, 2023.

    US STOCKS-Futures muted as investors await key inflation data

    U.S. stock index futures were flat on Friday as investors steered clear of big bets ahead of crucial inflation data, amid receding fears of a banking crisis.

    09:16, 31 March 2023
    A file photo of the logo of Australian energy company Origin pictured in Melbourne, Australia, July 3, 2016

    Asia M&As drop to decade low as tumultuous backdrop deters dealmaking

    Mergers and acquisitions (M&A) in the Asia-Pacific region fell to a decade low in the first three months of this year as a tumultuous geopolitical and macroeconomic environment left dealmakers cautious.

    09:14, 31 March 2023
    A file photo of a worker shoveling coal in a supply truck at a yard on the outskirts of Ahmedabad, India, October 25, 2018.

    Coal India surpasses annual output target for first time in 17 years

    Coal India Ltd said on Friday it had breached its annual production target of 700 million tonnes, the first time it had surpassed its goal since the fiscal year that ended in March 2006.

    09:13, 31 March 2023
    A file photo of bull and bear symbols in front of the German stock exchange in Frankfurt, Germany, February 12, 2019.

    Global IPOs marred by banks and recession enjoy few bright spots

    A banking crisis and worries of a recession have dampened the outlook for initial public offerings (IPOs) this year, prompting companies to slow down their plans to go public in what is likely to result in lower fees for investment banks.

    09:06, 31 March 2023
    A file photo of Unicredit Bank logo seen in this illustration taken March 12, 2023.

    UniCredit shareholders gather to vote on CEO's new pay scheme

    Shareholders in UniCredit met on Friday to vote on a new pay scheme for Chief Executive Andrea Orcel designed to reward outperformance with a 30% pay raise.

    09:04, 31 March 2023

    People also watch

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Long position overnight fee -0.0249%
    Short position overnight fee 0.0027%
    Overnight fee time 21:00 (UTC)
    Spread 3.0

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Long position overnight fee -0.0156%
    Short position overnight fee -0.0063%
    Overnight fee time 21:00 (UTC)
    Spread 0.03

    Natural Gas

    2.20 Price
    +3.540% 1D Chg, %
    Long position overnight fee -0.4092%
    Short position overnight fee 0.3873%
    Overnight fee time 21:00 (UTC)
    Spread 0.005

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Long position overnight fee -0.0185%
    Short position overnight fee 0.0102%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 500.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading